Literature DB >> 32803317

Gender-specific SBNO2 and VPS13B as a potential driver of osteoporosis development in male ankylosing spondylitis.

T Li1, W-B Liu1, F-F Tian2, J-J Jiang2, Q Wang1, F-Q Hu1, W-H Hu3,4, X-S Zhang5.   

Abstract

To identify the critical genes and pathways that related to OP development in male AS patients, bioinformatic gene analysis and qRT-PCR validation were performed. SBNO2 and VPS13B were identified as the potential target for OP development, which may be valuable for the prevention of OP in male AS patients.
INTRODUCTION: Osteoporosis (OP) is common in men with ankylosing spondylitis (AS). The specific pathogenesis of OP in AS, however, is still unclear. The present study attempted to identify potential genes associated with the development of OP in males with AS.
METHODS: Gene expression profiles were downloaded from the GSE73754 and GSE35959 datasets from the Gene Expression Omnibus (GEO). Data from OsteoporosAtlas were downloaded as a supplement. Differentially expressed genes (DEGs) were determined with the limma package. The overlapping DEGs between male AS-related genes and OP-related genes were determined. The DEGs were validated by qRT-PCR in the blood samples of males with AS. Weighted gene co-expression network analysis (WGCNA) was utilized to establish a co-expression network to identify the hub genes.
RESULTS: A total of 17 overlapping DEGs were identified; 6 genes in 17 overlapping DEGs were verified as the essential genes in the pathogenesis of OP in male AS by qRT-PCR analysis. After WGCNA, the modules of MEblue (> 0.6) and MEred (> 0.8) were screened out by the correlation analysis and were determined to function mainly in MAPK signaling pathway and osteoclast differentiation. Analysis of the two modules revealed VPS13B and SBNO2 as key genes due to the high degree of correlation. Both genes play an important role in bone metabolism regulation in male AS. Two hub genes MYD88 in MEblue and NCK1 in MEred with high degree of connectivity were selected.
CONCLUSIONS: Gender-specific SBNO2 and VPS13B may be key genes involved in OP in male AS.

Entities:  

Keywords:  Ankylosing spondylitis; Bioinformatics analysis; Key genes; Male; Osteoporosis

Mesh:

Substances:

Year:  2020        PMID: 32803317     DOI: 10.1007/s00198-020-05593-9

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  3 in total

1.  Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes.

Authors:  Kirsten Karberg; Jane Zochling; Joachim Sieper; Dieter Felsenberg; Juergen Braun
Journal:  J Rheumatol       Date:  2005-07       Impact factor: 4.666

2.  Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis.

Authors:  Helmut Franck; Thomas Meurer; Lorenz Christian Hofbauer
Journal:  J Rheumatol       Date:  2004-11       Impact factor: 4.666

Review 3.  How should clinicians manage osteoporosis in ankylosing spondylitis?

Authors:  Rupa Bessant; Andrew Keat
Journal:  J Rheumatol       Date:  2002-07       Impact factor: 4.666

  3 in total
  1 in total

1.  Bidirectional relationship between temporomandibular disorder and ankylosing spondylitis: a population-based cohort study.

Authors:  Yi-Fang Huang; Chung-Ta Chang; Chih-Hsin Muo; Kuan-Ming Chiu; Chun-Hao Tsai; Shih-Ping Liu
Journal:  Clin Oral Investig       Date:  2021-04-14       Impact factor: 3.573

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.